The results of the 2022 National Youth Tobacco Survey released today show that youth e-cigarette use remains an urgent public health problem in the United States, and it continues to be driven by the widespread availability of flavored products that the FDA ...
Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 pounds). Today’s action marks the first ...